Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Solid Tumor × atezolizumab × Clear all

Phase

Status

Terminated 2 Completed 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 20 Lung Neoplasms 12 Carcinoma, Hepatocellular 11 Colorectal Neoplasms 10 Urinary Bladder Neoplasms 8 Small Cell Lung Carcinoma 8 Breast Neoplasms 8 Neoplasms 7 Neoplasm Metastasis 7 Carcinoma, Transitional Cell 7 Stomach Neoplasms 6 Triple Negative Breast Neoplasms 5 Melanoma 5 Glioblastoma 4 Carcinoma, Renal Cell 4 Uterine Cervical Neoplasms 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Endometrial Neoplasms 3 Turcot syndrome 2 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Nasopharyngeal Carcinoma 2 Mesothelioma, Malignant 2 Lymphoma, Follicular 2 Glioma 2 Extensive Stage Small Cell Lung Cancer 2 Carcinoma, Neuroendocrine 2 Carcinoma, Merkel Cell 2

Interventions

pembrolizumab 2 zimberelimab 1 tislelizumab 1 tilsotolimod 1 sintilimab 1 sacituzumab govitecan 1 niraparib 1 cobimetinib 1 cedazuridine 1 atezolizumab 1 Radiosurgery 1 Proton Therapy 1 Nivolumab 1 Ipilimumab 1 Injections 1 Everolimus 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04185831 2024-08-22

MEGALiT

Uppsala University Hospital

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡